This filing discloses that 2.6 million Medicare Advantage prescription drug plan enrollees lost coverage due to insurers discontinuing plans or exiting markets. Major players like UnitedHealth, Humana, and CVS Health are strategically shedding unprofitable Medicare Advantage business to protect earnings, impacting plan availability and choice for beneficiaries.
Approximately 2.6 million Medicare Advantage enrollees lost their plans in 2025 due to insurers discontinuing offerings or exiting specific counties. This trend is driven by a significant reduction in government reimbursement for Medicare Advantage plans (down ~20% from 2023 levels) while medical costs continue to rise. Major insurers like UnitedHealth, Humana, and CVS Health are strategically retreating from unprofitable markets to protect their margins, even if it means a decrease in membership. This move is generally positive for the profitability of these companies in the short-to-medium term, as they prioritize financial health over market share in less lucrative areas. However, it creates instability and reduced choice for beneficiaries, potentially leading to a shift back to Original Medicare for some. For investors, the key metric is now how well insurers manage medical costs relative to government payments, rather than just membership numbers. The slight federal payment increase for 2027 might slow the pace of exits but the underlying shift in power towards insurers remains.